articleTop 1% cited
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
The Lancet Oncology · 2015 · Vol. 16(9) · pp. 1090–1098
Joël Shapiro✉(Erasmus University Rotterdam)J. Jan B. van Lanschot(Erasmus University Rotterdam)Maarten C.C.M. Hulshof(Academic Medical Center)Pieter van Hagen(Erasmus MC)Mark I. van Berge Henegouwen(Academic Medical Center)Bas P. L. Wijnhoven(Erasmus MC)Hanneke W.M. van Laarhoven(Academic Medical Center)Grard A. P. Nieuwenhuijzen(Catharina Ziekenhuis)Geke A.P. Hospers(University Medical Center Groningen)Johannes J. Bonenkamp(Radboud University Medical Center)Miguel A. Cuesta(Amsterdam UMC Location VUmc)R.J.B. Blaisse(Rijnstate Hospital)Olivier R. Busch(Academic Medical Center)Fiebo J.W. ten Kate(Erasmus MC)Geert-Jan Creemers(Radboud University Nijmegen)Cornelis J.A. Punt(Radboud University Nijmegen)John Th. M. Plukker(University Medical Center Groningen)Henk M.W. Verheul(Amsterdam UMC Location VUmc)Ernst Jan Spillenaar Bilgen(Rijnstate Hospital)Herman van Dekken(Sint Lucas Andreas Hospital)Maurice J.C. van der Sangen(Catharina Ziekenhuis)Tom Rozema(Radboud University Medical Center)Katharina Biermann(Erasmus University Rotterdam)Jannet C. Beukema(University Medical Center Groningen)Anna H.M. Piet(Amsterdam UMC Location VUmc)Caroline M. van Rij(Erasmus University Rotterdam)Janny G. Reinders(Dutch Art Institute)Hugo W. Tilanus(Erasmus University Rotterdam)Ewout W. Steyerberg(Erasmus MC)Ate van der Gaast(Erasmus MC)
Esophageal Cancer Research and TreatmentGastric Cancer Management and OutcomesEsophageal and GI PathologyMedicineChemoradiotherapyCarboplatinSurgeryClinical endpointRadiation therapyCancerAdenocarcinomaClinical trialStage (stratigraphy)
MeSH terms
AdultAgedAntineoplastic Combined Chemotherapy ProtocolsEsophageal NeoplasmsEsophagogastric JunctionFemaleFluorouracilHumansMaleMiddle AgedNeoplasm StagingCarboplatinPaclitaxelDisease-Free SurvivalKaplan-Meier Estimate
Citations
2,497
FWCI
147.82
field-weighted impact
References
25
Percentile
100%
vs. same field & year
Citations per year
Cited by
Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS<sup>®</sup>) Society Recommendations
World Journal of Surgery · 2018 · 574 citations
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2016 · 1,108 citations
References
Proportional hazards tests and diagnostics based on weighted residuals
Biometrika · 1994 · 5,490 citations
Evaluating the Yield of Medical Tests
JAMA · 1982 · 3,381 citations
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
The Lancet Oncology · 2011 · 1,648 citations
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
New England Journal of Medicine · 2006 · 6,297 citations
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Journal of Clinical Oncology · 2011 · 2,078 citations
TNM Classification of Malignant Tumors
The American Journal of Surgical Pathology · 1998 · 6,357 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
